Floatz logo

Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Toripalimab
Triple-Negative Breast Carcinoma
Nanjing Leads Biolabs Co.,LtdP3BB (64)
TRASTUZUMAB
Gastric / Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan HospitalP3BB (64)
TRASTUZUMAB
Gastroesophageal Adenocarcinoma
UNICANCERP3BB (64)
Zilovertamab
Mantle Cell Lymphoma
Oncternal Therapeutics, IncP3BB (64)
Basiliximab
Acute Lymphoblastic Leukemia
City of Hope Medical CenterP2BB (64)
Basiliximab
Hodgkins Lymphoma
City of Hope Medical CenterP2BB (64)
Basiliximab
Myelodysplastic Syndrome
City of Hope Medical CenterP2BB (64)
Cetuximab
Colorectal Adenocarcinoma
BayerP2BB (64)
Durvalumab
Colorectal Carcinoma
Gruppo Oncologico del Nord-OvestP2BB (64)
Durvalumab
Pancreatic Adenocarcinoma
Jonsson Comprehensive Cancer CenterP2BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN 5'-NUCLEOTIDASE) (HUMAN MONOCLONAL MEDI9447 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI9447 .LAMBDA.-CHAIN, DIMER
Pancreatic Adenocarcinoma
M.D. Anderson Cancer CenterP2BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Triple-Positive Breast Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Acute Leukemia
SWOG Cancer Research NetworkP2BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
B-Cell Neoplasm
Curis, Inc.P2BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
OHSU Knight Cancer InstituteP2BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
T-Cell Acute Lymphoblastic Leukemia
University of WashingtonP2BB (64)
Ivonescimab
Metastatic Malignant Neoplasm
Revolution Medicines, Inc.P2BB (64)
Lorigerlimab
Castration-Resistant Prostate Carcinoma
MacroGenicsP2BB (64)
Nivolumab
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2BB (64)
Nivolumab
Diffuse Large B-Cell Lymphoma
David Bond, MDP2BB (64)
Nivolumab
Neuroblastoma
Instituto do Cancer do Estado de São PauloP2BB (64)
Nivolumab
Pancreatic Adenocarcinoma
Mayo ClinicP2BB (64)
Nivolumab
Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P2BB (64)
Nivolumab
Refractory Malignant Neoplasm
CatalYm GmbHP2BB (64)
Obinutuzumab
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2BB (64)
Showing 501 to 525 of 6,371 assets
PreviousPage 21 of 255Next